NEWTON BIOCAPITAL
Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases. Their approach as lead investor is to support promising start-up projects as well as neglected or undervalued late-stage projects, in order to mitigate the risks and to create investor value. The leadership team consi.sts of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects.
NEWTON BIOCAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2017-01-01
Status:
Active
Technology used in webpage:
Japanese Yen Combell
Similar Organizations
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-24 | NeuVasQ | Newton Biocapital investment in Series A - NeuVasQ | 20 M EUR |
| 2021-05-26 | EditForce | Newton Biocapital investment in Venture Round - EditForce | 800 M JPY |
| 2021-02-24 | DeuterOncology | Newton Biocapital investment in Seed Round - DeuterOncology | N/A |
| 2020-11-30 | Perseus Proteomics | Newton Biocapital investment in Venture Round - Perseus Proteomics | 140 M JPY |
| 2020-11-04 | AbolerIS Pharma | Newton Biocapital investment in Seed Round - AbolerIS Pharma | 2.5 M EUR |
| 2020-07-30 | J-Pharma | Newton Biocapital investment in Series D - J-Pharma | 1.75 M JPY |
| 2019-11-06 | Acticor Biotech | Newton Biocapital investment in Series B - Acticor Biotech | 7 M EUR |
| 2019-03-01 | EditForce | Newton Biocapital investment in Series B - EditForce | 870 M JPY |
| 2018-10-17 | Acticor Biotech | Newton Biocapital investment in Series B - Acticor Biotech | 15.3 M EUR |
| 2018-10-16 | Sequana Medical | Newton Biocapital investment in Series D - Sequana Medical | 8.5 M EUR |
More informations about "Newton Biocapital"
Newton Biocapital - Life Sciences Investments
We support projects for promising solutions in chronic health conditions, with a focus on alleviating patient and societal burdens. Drawing on our team’s scientific and medical know …See details»
About | Newton Biocapital - Life Sciences Investments
By leveraging innovation to develop solutions for chronic health conditions, we help create value for: Patients, by funding efforts for affordable healthcare solutions matching unmet medical needs. Society, by easing pressure on …See details»
Newton Biocapital - Crunchbase Investor Profile & Investments
Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases. Newton Biocapital invests in early-stage biotechnology, …See details»
Funds | Newton Biocapital - Life Sciences Investments
Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and…See details»
NEWTON BIOCAPITAL - LinkedIn
Newton Biocapital (NBC) is a VC firm focused on early-stage Life Sciences companies targeting chronic health conditions. NBC is among the 8 VC firms certified by AMED in Japan to boost the...See details»
Newton Biocapital - Investments, Portfolio & Company Exits
Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.See details»
Newton BioCapital investment portfolio - PitchBook
Founded in 2017, Newton BioCapital is a venture capital investment firm based in Brussels, Belgium. The firm focuses on investing in biotech and life science sectors in Europe and Japan. You’re viewing 10 of 30 investments. Get the full …See details»
Newton BioCapital | Institution Profile - Private Equity International
Newton BioCapital is a Brussels-based venture capital business that was established in 2017. The firm focuses on making investments in Europe's biotech and life science industries.See details»
Newton Biocapital | flanders.bio
Jul 4, 2017 · Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for …See details»
Newton Biocapital - CB Insights
Newton Biocapital is a Belgian venture capital fund focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of …See details»
Newton Biocapital - Funding, Financials, Valuation & Investors
Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.See details»
Strategy | Newton Biocapital - Life Sciences Investments
We help establish and fund early-stage companies ranging from research and preclinical through to clinical. We help our companies select the indications most likely to reach proof of concept …See details»
Newton Biocapital VC Fund Leads Investment Wave in Japanese …
Feb 18, 2022 · As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital firm Newton Biocapital has launched a €150M fund to harness synergy …See details»
Newton Biocapital I: Fund Performance - PitchBook
Aug 1, 2023 · Newton Biocapital I is an early stage venture capital fund managed by Newton BioCapital. The fund is located in Brussels, Belgium and invests in Europe and Japan. The …See details»
Life Sciences Investments - Newton Biocapital
Feb 15, 2022 · Newton Biocapital is a venture capital firm incorporated in Belgium, established in 2017. Newton invests in pre-clinical and clinical-stage companies in Europe and Japan, where …See details»
Newton Biocapital launches a new fund with initial capital ... - BioVox
Feb 15, 2022 · Newton Biocapital is a venture capital firm incorporated in Belgium, established in 2017. Newton invests in pre-clinical and clinical-stage companies in Europe and Japan, where …See details»
Newton Biocapital - Contacts, Employees, Board Members
Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.See details»
Team | Newton Biocapital - Life Sciences Investments
With offices in both Brussels and Tokyo, our team works together to enhance collaboration between regions. Our team members have backgrounds in science, industry, and venture …See details»
Newton Biocapital invests in NeuVasQ: EUR 20 million Series A
Brussels, Belgium, 22 June 2021 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe and Japan focused on chronic diseases, has announced its investment …See details»